Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
COLIBRI
Effects of Coffees With Various Compositions of Antioxidants on Hepatic Steatosis Induced by a High Fructose, Hypercaloric Diet
1 other identifier
interventional
13
1 country
1
Brief Summary
This study will assess
- whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans
- whether the protective effect of coffee is dependent on it's antioxidant composition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2009
CompletedFirst Posted
Study publicly available on registry
January 22, 2009
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFebruary 24, 2012
February 1, 2012
1.8 years
January 20, 2009
February 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intra-hepatocellular lipid (IHCL) concentration
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
Secondary Outcomes (6)
fasting plasma triglycerides
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
fasting net lipid oxidation
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
fasting net carbohydrate oxidation
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
whole body ketone bodies turnover and oxidation (13C 3-hydroxybutyrate)
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
whole body glucose turnover (6,6 2H2 glucose)
will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement
- +1 more secondary outcomes
Study Arms (5)
Ctl
PLACEBO COMPARATORcontrol isocaloric diet; no coffee
HF
PLACEBO COMPARATORHypercaloric. high fructose diet; no coffee
C1
EXPERIMENTALHypercaloric, high fructose diet; caffeine-free, torrefied coffee
C2
EXPERIMENTALHypercaloric, high fructose diet; caffeine-free, partially torrefied coffee
C3
EXPERIMENTALHypercaloric, high fructose diet; caffeinated, partially torrefied coffee
Interventions
Hypercaloric, high fructose diet + coffee
Hypercaloric, high fructose diet + coffee
Eligibility Criteria
You may qualify if:
- BMI between 19 and 15 kg/m2
- less than 30 min physical activity /day
- habitual coffee consumption less than three cupy /day
- consumption of caffeine-containing sodas less than 2 servings/day
- non-smoker
You may not qualify if:
- consumption of alcohol more than 40g/day
- presence of metallic foreign bodies
- history of eye surgery
- family history of diabetes mellitus
- history of food intolerance
- vegetarians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre d'investigations cliniques "cardiomet"/ CHUV
Lausanne, CH-1011, Switzerland
Related Publications (1)
Lecoultre V, Carrel G, Egli L, Binnert C, Boss A, MacMillan EL, Kreis R, Boesch C, Darimont C, Tappy L. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men. Am J Clin Nutr. 2014 Feb;99(2):268-75. doi: 10.3945/ajcn.113.069526. Epub 2013 Nov 20.
PMID: 24257718DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luc Tappy, MD
Department of Physiology, University of Lausanne, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of physiology
Study Record Dates
First Submitted
January 20, 2009
First Posted
January 22, 2009
Study Start
February 1, 2009
Primary Completion
December 1, 2010
Study Completion
March 1, 2011
Last Updated
February 24, 2012
Record last verified: 2012-02